CD4 cell count and viral load-specific rates of AIDS, non-AIDS and deaths according to current antiretroviral use
Research output: Contribution to journal › Journal article › Research › peer-review
CD4 cell count and viral loads are used in clinical trials as surrogate endpoints for assessing efficacy of newly available antiretrovirals. If antiretrovirals act through other pathways or increase the risk of disease this would not be identified prior to licensing. The aim of this study was to investigate the CD4 cell count and viral load-specific rates of fatal and nonfatal AIDS and non-AIDS events according to current antiretrovirals.
Original language | English |
---|---|
Journal | AIDS (London, England) |
Volume | 27 |
Issue number | 6 |
Pages (from-to) | 907-18 |
Number of pages | 12 |
DOIs | |
Publication status | Published - 27 Mar 2013 |
- Acquired Immunodeficiency Syndrome, Adult, Anti-Retroviral Agents, CD4 Lymphocyte Count, Cohort Studies, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies, Survival Analysis, Viral Load
Research areas
ID: 105605285